36 results about "Cutaneous inflammation" patented technology

The invention belongs to the field of daily chemical industry, especially relates to a daily skin care product and particularly relates to a multi-effect moisturizing and softening composition which can be used for regularizing skin, maintaining the water balance of skin, curing inflamed skin and erythema phenomena, prompting skin regeneration, refreshing and the like. The multi-effect moisturizing and softening composition comprises the following ingredients: oat glucan, bean collagen, aloe extract, microcapsule-coated ultraviolet absorbent, phytosterols, hydrogenated rosin glycerin ester, jojoba oil, natural squalane, siloxane, a natural an emulsifier, a water-phase thickener, a chelating agent, Ethylhexylglycerin, pentylene glycol, phenoxyethanol and water. The invention designs a temperate and multi-effect and high plant-content multi-effect moisturizing and softening composition through reasonably using and matching all ingredients. The multi-effect moisturizing and softening composition mainly aims at erythema, inflammation, crack, scratch and other problems, has the effects of moisturizing, softening, moisturizing, prompting skin regeneration, refreshing and the like, thus being an necessary daily caring and traveling skincare product.

The present invention is directed to a treatment for sunburn and a method for preventing sunburn. One aspect of this invention involves a sunburn treatment comprising one or more polypeptides with an amino acid sequence including KPV (SEQ. ID. NO. 1), MEHFRWG (SEQ. ID. NO. 2), HFRWGKPV (SEQ. ID. NO. 3), or SYSMEHFRWGKPV (SEQ. ID. NO. 4) for the treatment of the cutaneous inflammation caused by exposure to ultraviolet radiation. The polypeptides are at a level to effectively treat the cutaneous inflammation and are carried by a carrier. The one or more polypeptides can also be a dimer formed from any of the amino acid sequence above. In one preferred embodiment of the invention, the one or more polypeptides are used to prevent sunburn. In another preferred embodiment, the one or more polypeptides are dissolved in a carrier. In another preferred embodiment, the carrier includes aloe vera and lidocaine hydrochloride. In another preferred embodiment of the invention, the one or more polypeptides are dissolved in a liquid that is associated with an absorbent material for application to sunburned skin.

The invention discloses a medicine for treating acne, which is used for solving the problems that western medicine treatment is long in process, large in side effect and apt to reoccur and is prepared by fructus forsythiae, honeysuckle, Chinese violet, golden cypress, Sargassum, Sargent gloryvine, astragali radix, root of common peony and fructus kochiae. The medicine is used for treating acne, can reduce sebum secretion of sebaceous glands, restrains growth of bacteria in folliculus pili, reduces cutaneous inflammation reaction, promotes absorbing and diffusion of red and swollen nodules of folliculus pili portions, and achieves satisfied curative effects clinically. The medicine for treating acne is rigorous in compatibility of medicines, scientific, reasonable, low in cost, good in curative rate, short in course of treatment, convenient to use and not apt to reoccur and can be used for treating acne.

The invention relates to a stoma skin protective agent and a preparation method thereof, chitosan is fully dissolved in water, chitosan is used as a hydrogel matrix, hydrogel is obtained by using chitosan with molecular weight of 25000g/mol to 150000g/mol and deacetylation grade higher than 85%, and the stoma skin protective agent has better antibacterial effect compared with many hydrogel such asPVA and PVP hydrogel on the market; in order to improve the properties of the hydrogel, purslane and at least one preservative are added, so that the antibacterial and anti-inflammatory effects are further improved; meanwhile, the panthenol is added and interacts with other components, so that the damaged skin can be repaired, and the generation of new cells is accelerated. The protective agent disclosed by the invention is good in treatment effect, can effectively relieve skin inflammation of a stoma patient, and particularly can effectively help healing when the skin of the stoma patient isulcerated.

The invention relates to the technical field of cosmetics and in particular discloses a tripeptide anti-allergy essence. The three-peptide anti-allergy essence comprises the following effective components in percentage by weight: 0.5 to 2 percent of Corallina officinalis extract; 1 to 3 percent of yeast skin whitening agent, 0.5 to 3 percent of honey extract, 0.3 to 3 percent of purslane extract and 0.3 to 5 percent of bradykinin solution. Since the tripeptide anti-allergy essence contains the relieving peptide solution, the production of TNF-alpha can be interfered, angioneurotic edema is reduced and cutaneous inflammation reaction is fundamentally and effectively reduced.

Methods for treating allergies, cutaneous inflammation, arthritis, chronic obstruction pulmonary disease and treating chronic inflammatory bowel disease are described. Also described is a method for inhibiting the infiltration of eosinophils into airways of a patient, a method for inhibiting the mucous release into airways of a patient, a method for blocking lgE activation of a lymphocyte, a method for stabillizing the cell membrane of a lymphocyte, thereby preventing their further involvement in the increased inflammatory response to an lgE antigen challenge, and a method for inhibiting the migration of T-cells. Such methods involve administering to said patient a therapeutically effective amount of a peptide having the formula f-Met-Leu-X, wherein X is selected from the group consisting of Tyr, Try-Phe, Phe-Phe and Phe-Tyr.

The present invention provides a composition for transdermally permeating a macromolecular drug wherein the composition comprises an extract of a plant causing a skin inflammatory response, which extract can be used to prepare a composition for transdermally permeating a macromolecular drug, forming a transdermal drug delivery system. The composition can comprise a vasodilator, so as to improve the efficacy of the macromolecular drug penetrating into the blood through the skin.

The invention relates to peptides capable of inhibiting neuronal exocytosis and to products comprising such peptides, in particular pharmaceutical and cosmetic products useful for ameliorating skin conditions, disorders and/or diseases mediated by neuronal exocytosis, such as wrinkles, excessive perspiration, pruritus, cutaneous inflammation, dermatitis, atopia, psoriasis, vascular hyperreactivity, rosacea, acne, hair growth, wound healing, calluses, warts, or sensitive skin conditions, such as ulcers and lesions on the skin.